Your browser doesn't support javascript.
loading
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.
Eckardt, Jan-Niklas; Stasik, Sebastian; Röllig, Christoph; Petzold, Andreas; Sauer, Tim; Scholl, Sebastian; Hochhaus, Andreas; Crysandt, Martina; Brümmendorf, Tim H; Naumann, Ralph; Steffen, Björn; Kunzmann, Volker; Einsele, Hermann; Schaich, Markus; Burchert, Andreas; Neubauer, Andreas; Schäfer-Eckart, Kerstin; Schliemann, Christoph; Krause, Stefan W; Herbst, Regina; Hänel, Mathias; Hanoun, Maher; Kaiser, Ulrich; Kaufmann, Martin; Rácil, Zdenek; Mayer, Jiri; Oelschlägel, Uta; Berdel, Wolfgang E; Ehninger, Gerhard; Serve, Hubert; Müller-Tidow, Carsten; Platzbecker, Uwe; Baldus, Claudia D; Dahl, Andreas; Schetelig, Johannes; Bornhäuser, Martin; Middeke, Jan Moritz; Thiede, Christian.
Affiliation
  • Eckardt JN; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany. jan-niklas.eckardt@uniklinikum-dresden.de.
  • Stasik S; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Röllig C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Petzold A; Dresden-Concept Genome Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.
  • Sauer T; German Cancer Research Center (DKFZ) and Medical Clinic V, University Hospital Heidelberg, Heidelberg, Germany.
  • Scholl S; Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany.
  • Hochhaus A; Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany.
  • Crysandt M; Department of Hematology, Oncology, Hemostaseology, and Cell Therapy, University Hospital RWTH Aachen, Aachen, Germany.
  • Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Cell Therapy, University Hospital RWTH Aachen, Aachen, Germany.
  • Naumann R; Medical Clinic III, St. Marien-Hospital Siegen, Siegen, Germany.
  • Steffen B; Medical Clinic II, University Hospital Frankfurt, Frankfurt (Main), Germany.
  • Kunzmann V; Medical Clinic and Policlinic II, University Hospital Würzburg, Würzburg, Germany.
  • Einsele H; Medical Clinic and Policlinic II, University Hospital Würzburg, Würzburg, Germany.
  • Schaich M; Department of Hematology, Oncology and Palliative Care, Rems-Murr-Hospital Winnenden, Winnenden, Germany.
  • Burchert A; Department of Hematology, Oncology and Immunology, Philipps-University-Marburg, Marburg, Germany.
  • Neubauer A; Department of Hematology, Oncology and Immunology, Philipps-University-Marburg, Marburg, Germany.
  • Schäfer-Eckart K; Department of Internal Medicine V, Paracelsus Medizinische Privatuniversität and University Hospital Nuremberg, Nuremberg, Germany.
  • Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Krause SW; Medical Clinic V, University Hospital Erlangen, Erlangen, Germany.
  • Herbst R; Medical Clinic III, Chemnitz Hospital AG, Chemnitz, Germany.
  • Hänel M; Medical Clinic III, Chemnitz Hospital AG, Chemnitz, Germany.
  • Hanoun M; Department of Hematology, University Hospital Essen, Essen, Germany.
  • Kaiser U; Medical Clinic II, St. Bernward Hospital, Hildesheim, Germany.
  • Kaufmann M; Department of Hematology, Oncology and Palliative Care, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Rácil Z; Department of Internal Medicine, Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic.
  • Mayer J; Department of Internal Medicine, Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic.
  • Oelschlägel U; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Berdel WE; Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Ehninger G; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Serve H; Medical Clinic II, University Hospital Frankfurt, Frankfurt (Main), Germany.
  • Müller-Tidow C; German Cancer Research Center (DKFZ) and Medical Clinic V, University Hospital Heidelberg, Heidelberg, Germany.
  • Platzbecker U; Medical Clinic I Hematology and Celltherapy, University Hospital Leipzig, Leipzig, Germany.
  • Baldus CD; Department of Internal Medicine, University Hospital Kiel, Kiel, Germany.
  • Dahl A; Dresden-Concept Genome Center, Center for Molecular and Cellular Bioengineering, Technische Universität Dresden, Dresden, Germany.
  • Schetelig J; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Bornhäuser M; DKMS Clinical Trials Unit, Dresden, Germany.
  • Middeke JM; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Thiede C; German Consortium for Translational Cancer Research DKFZ, Heidelberg, Germany.
Leukemia ; 37(12): 2395-2403, 2023 12.
Article in En | MEDLINE | ID: mdl-37833543
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Limits: Adult / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Limits: Adult / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United kingdom